BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12140148)

  • 1. Gemcitabine and vascular toxicity.
    Muñoz A; Mañé JM; Rubio I; Fernández R; Fuente N; Barceló R; López Vivanco G
    Lung Cancer; 2002 Aug; 37(2):229. PubMed ID: 12140148
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasculitis due to gemcitabine.
    Voorburg AM; van Beek FT; Slee PH; Seldenrijk CA; Schramel FM
    Lung Cancer; 2002 May; 36(2):203-5. PubMed ID: 11955656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purtscher retinopathy and necrotizing vasculitis with gemcitabine therapy.
    Banach MJ; Williams GA
    Arch Ophthalmol; 2000 May; 118(5):726-7. PubMed ID: 10815173
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal pulmonary veno-occlusive disease possibly related to gemcitabine.
    Vansteenkiste JF; Bomans P; Verbeken EK; Nackaerts KL; Demedts MG
    Lung Cancer; 2001 Jan; 31(1):83-5. PubMed ID: 11162870
    [No Abstract]   [Full Text] [Related]  

  • 5. Veno-occlusive disease of the liver induced by gemcitabine.
    Dobbie M; Hofer S; Oberholzer M; Herrmann R
    Ann Oncol; 1998 Jun; 9(6):681. PubMed ID: 9681086
    [No Abstract]   [Full Text] [Related]  

  • 6. Gemcitabine for lung cancer.
    Drug Ther Bull; 1996 Sep; 34(9):71-2. PubMed ID: 8885499
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of gemcitabine toxicity with a brief course of oral corticosteroid therapy.
    Vander Els NJ; Miller V
    Chest; 1998 Dec; 114(6):1779-81. PubMed ID: 9872221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine hydrochloride: combination of activity and tolerability. Proceedings of a symposium. Jerusalem, Israel, November 14, 1993.
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():5-65. PubMed ID: 8718418
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe neurotoxicity caused by gemcitabine treatment.
    Larsen FO; Hansen SW
    Acta Oncol; 2004; 43(6):590-1. PubMed ID: 15370618
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interstitial lung disease in a patient given gemcitabine].
    Hammerer V; Schmitz N; Pauli G; Quoix E
    Rev Pneumol Clin; 2002 Feb; 58(1):23-6. PubMed ID: 11981501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic-uremic syndrome caused by gemcitabine.
    Nackaerts K; Daenen M; Vansteenkiste J; Vandevelde A; Van Bleyenbergh P; Demedts M
    Ann Oncol; 1998 Dec; 9(12):1355. PubMed ID: 9932169
    [No Abstract]   [Full Text] [Related]  

  • 12. An unusual case of gemcitabine-induced radiation recall.
    Squire S; Chan M; Feller E; Mega A; Gold R
    Am J Clin Oncol; 2006 Dec; 29(6):636. PubMed ID: 17149004
    [No Abstract]   [Full Text] [Related]  

  • 13. Sonography and CT of vasculitis during gemcitabine therapy.
    Bendix N; Glodny B; Bernathova M; Bodner G
    AJR Am J Roentgenol; 2005 Mar; 184(3 Suppl):S14-5. PubMed ID: 15728007
    [No Abstract]   [Full Text] [Related]  

  • 14. [Severe ischemic myopathy localized in an irradiated area following gemcitabine therapy].
    Pariente A; Berthelémy P; Arotçarena R; Bénichou M; Calès V; Dujols JP
    Presse Med; 2000 Oct; 29(30):1650. PubMed ID: 11089501
    [No Abstract]   [Full Text] [Related]  

  • 15. Gemcitabine associated vasculitis leading to necrotizing enterocolitis and death in women undergoing primary treatment for epithelial ovarian/peritoneal cancer.
    Geisler JP; Schraith DF; Manahan KJ; Sorosky JI
    Gynecol Oncol; 2004 Feb; 92(2):705-7. PubMed ID: 14766271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine--a major advance?
    Thomas A; Steward WP
    Ann Oncol; 1998 Dec; 9(12):1265-7. PubMed ID: 9932153
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiation myositis: the possible role of gemcitabine.
    Ganem G; Solal-Celigny P; Joffroy A; Tassy D; Delpon A; Dupuis O
    Ann Oncol; 2000 Dec; 11(12):1615-6. PubMed ID: 11205473
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous vasculitis associated with gemcitabine therapy.
    Corella F; Dalmau J; Roé E; García-Navarro X; Alomar A
    Clin Exp Dermatol; 2009 Jan; 34(1):97-9. PubMed ID: 19076809
    [No Abstract]   [Full Text] [Related]  

  • 19. [Severe interstitial pneumonitis related to Gemcitabine].
    Sabria-Trias J; Bonnaud F; Sioniac M
    Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe pulmonary toxicity in a patient treated with gemcitabine.
    Rosado MF; Kett DH; Schein RM; Baraona FJ; Sridhar KS
    Am J Clin Oncol; 2002 Feb; 25(1):31-3. PubMed ID: 11823691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.